Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nuvalent, Inc. | 8,299,225 | reported | 24 Nov 2025 | tx 6+12,576−742,574 |
| ANTARES PHARMA INC | 6,807,533 | reported | 30 Sept 2015 | tx 15−1,828,529 |
| AdaptHealth Corp. | 6,045,652 | reported | 02 Apr 2018 | tx 5+7,666,666−925,761 |
| ARS Pharmaceuticals, Inc. | 4,887,254 | reported | 27 Jun 2025 | tx 2−740,149 |
| ALIMERA SCIENCES INC | 4,624,284 | reported | 03 Dec 2015 | tx 6+243,252 |
| SALIX PHARMACEUTICALS LTD | 3,913,471 | reported | 30 Dec 2008 | tx 6+308,400 |
| Hana Biosciences Inc | 2,974,566 | reported | 16 Jul 2013 | tx 72+26,969,971−28,550,400 |
| Werewolf Therapeutics, Inc. | 2,552,787 | reported | 04 May 2021 | tx 3+2,552,787−15,195,094 |
| CAS MEDICAL SYSTEMS INC | 2,358,636 | reported | 26 Jan 2017 | tx 3−636,238 |
| MEDICINES CO /DE | 2,325,237 | reported | 06 Apr 2011 | tx 24+667,040−436,999 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Larimar Therapeutics, Inc. | 55,150 | 0.00 USD | deriv |
| 24 Nov 2025 | SALE | Nuvalent, Inc. | 371,287 | 95.45 USD | |
| 24 Nov 2025 | SALE | Nuvalent, Inc. | 371,287 | 95.45 USD | |
| 27 Jun 2025 | SALE | ARS Pharmaceuticals, Inc. | 370,074 | 18.46 USD | |
| 27 Jun 2025 | SALE | ARS Pharmaceuticals, Inc. | 370,075 | 18.46 USD | |
| 27 Jan 2025 | OTHER | Acutus Medical, Inc. | 1,889,509 | — | deriv |
| 27 Jan 2025 | OTHER | Acutus Medical, Inc. | 209,996 | — | deriv |
| 27 Jan 2025 | OTHER | Acutus Medical, Inc. | 1,889,509 | — | deriv |
| 27 Jan 2025 | OTHER | Acutus Medical, Inc. | 31,116 | — | deriv |
| 27 Jan 2025 | OTHER | Acutus Medical, Inc. | 193,002 | — | deriv |
| 11 Jul 2024 | GRANT_AWARD | BiomX Inc. | 264,000 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | Nuvalent, Inc. | 2,499 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | Nuvalent, Inc. | 2,499 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | Nuvalent, Inc. | 3,789 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | Nuvalent, Inc. | 3,789 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Larimar Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 17 Nov 2023 | EXERCISE | Deerfield Healthcare Technology Acquisitions Corp. | 12,123 | — | |
| 17 Nov 2023 | EXERCISE | Deerfield Healthcare Technology Acquisitions Corp. | 12,123 | 0.00 USD | deriv |
| 28 Jul 2023 | OTHER | DA32 Life Science Tech Acquisition Corp. | 1,600,000 | — | |
| 16 Jun 2022 | GRANT_AWARD | Acutus Medical, Inc. | 8,400 | 0.00 USD | |
| 15 Jun 2023 | GRANT_AWARD | Acutus Medical, Inc. | 8,400 | 0.00 USD | |
| 15 Jun 2023 | GRANT_AWARD | Acutus Medical, Inc. | 19,600 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | Acutus Medical, Inc. | 19,600 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Deerfield Healthcare Technology Acquisitions Corp. | 33,750 | 0.00 USD | deriv |
| 28 Dec 2022 | SALE | Oncorus, Inc. | 24,757 | 0.25 USD |
5 purchases reported after at least 12 months of silence — most recent on 09 Feb 2021.